| Created for Canadian Breast Cancer Network “Precision oncology involves knowing about the tumour and the patient, and using this information to assess appropriate treatment,” says Dr. Karen A. Gelmon, professor of medicine, University of British Columbia and medical oncologist, BC Cancer. Equitable access for all Canadian breast cancer patients means they can make knowledgeable decisions about future treatments. A recent Canadian Breast Cancer Network report calls for a national framework to guide genomic testing use and ensure timely patient access to testing and treatment. |
